Plain-English translation of NCT06792149 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Researchers are testing whether they can grow miniature models of your stomach cancer tumor in the lab using 3D bioprinting technology. They'll then test the same chemotherapy drugs that your doctor plans to give you against these lab-grown models to see how well they work. This could help doctors predict which treatments will be most effective for your specific cancer before you start chemotherapy.
Stomach cancer treatment plans are usually chosen based on general guidelines and doctors' experience, not on what will work best for each individual patient. This trial aims to see whether testing your tumor against medications in the lab first could help doctors pick the most effective treatment plan just for you.
If you qualify, researchers will collect a small sample of your tumor tissue during your surgery. This sample will be used to grow lab models of your cancer, which will then be tested against the chemotherapy drugs your doctor plans to use. Your doctors will continue treating you normally, and researchers will track how well the treatment actually works for you over time to see if their lab predictions matched real results.
AI-generated summary from trial data · Jun 7, 2026 · Not medical advice
China
Enrollment target
~60 participants
Started
October 2023
Primary completion
October 2025
Age range
18 Years and older
Last updated on clinicaltrials.gov in January 2025.
Reach out to the team running this trial. Response times vary — some teams are faster than others.
Central contact
HuaYu Yang, PhD
Peking Union Medical College Hospital